Literature DB >> 1792317

Three-dimensional dose distribution of tangential breast treatment: a national dosimetry intercomparison.

N A van Bree1, L J van Battum, H Huizenga, B J Mijnheer.   

Abstract

From August 1990 to February 1991, a dosimetry intercomparison of breast treatment was performed at all 21 radiotherapy centres in The Netherlands. The absorbed dose was measured in three planes in a breast phantom during tangential breast irradiation, according to a prescribed technique. The beam energy could be chosen by the radiotherapy centre as normally applied for this type of "patient", and varied between 60Co and 8 MV X rays. The dose measured by the visiting team in 22 points inside the phantom was compared with the dose calculated by the institution using their local treatment planning system. In the institutions the mean ratio (the mean value of the ratios of the absolute calculated dose and the measured absolute dose in the 22 points) varied between 0.92 and 1.08 with an overall mean ratio of 1.04. There was no significant difference in this ratio between the three planes in a particular institution. In the isocentre the mean ratio of calculated and measured dose was 1.021 with a SD of 0.028, i.e. the algorithms in the six different commercial treatment planning systems calculate the dose generally somewhat too high. In order to explain the results, a measurement of the output under reference conditions was performed at each treatment unit. The mean ratio of the dose stated by the institution and the dose measured by the visiting team was 1.011 with a SD of 0.015 with a maximum deviation of 0.040. This small deviation explains therefore only part of the variation in the ratio of calculated and measured dose for tangential breast irradiation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1792317     DOI: 10.1016/0167-8140(91)90159-e

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  Quality assurance of the EORTC Trial 22881/10882: boost versus no boost in breast conserving therapy. An overview.

Authors:  G van Tienhoven; B J Mijnheer; H Bartelink; D G González
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

2.  Anthropomorphic breast phantoms for quality assurance and dose verification.

Authors:  José A Bencomo; Connel Chu; Victor M Tello; Sang Hyun Cho; Geoffrey S Ibbott
Journal:  J Appl Clin Med Phys       Date:  2004-01-01       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.